141 related articles for article (PubMed ID: 2524116)
1. Direct demonstration of D1 dopamine receptors in the bovine parathyroid gland using the D1 selective antagonist [125I]-SCH 23982.
Monsma FJ; Sibley DR
Synapse; 1989; 3(3):193-9. PubMed ID: 2524116
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1 receptors of the calf parathyroid gland: identification and characterization.
Niznik HB; Fogel EL; Chen CJ; Congo D; Brown EM; Seeman P
Mol Pharmacol; 1988 Jul; 34(1):29-36. PubMed ID: 2839763
[TBL] [Abstract][Full Text] [Related]
3. Characterization of D1 dopamine receptors in the bovine pineal gland with [3H]SCH 23390.
Simonneaux V; Murrin LC; Ebadi M
J Pharmacol Exp Ther; 1990 Apr; 253(1):214-20. PubMed ID: 2139469
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein nature of dopamine D1 receptors in the brain and parathyroid gland.
Jarvie KR; Booth G; Brown EM; Niznik HB
Mol Pharmacol; 1989 Oct; 36(4):566-74. PubMed ID: 2682204
[TBL] [Abstract][Full Text] [Related]
5. Beta 1-adrenergic and dopamine (D1)-receptors coupled to adenylyl cyclase activation in GT1 gonadotropin-releasing hormone neurosecretory cells.
Findell PR; Wong KH; Jackman JK; Daniels DV
Endocrinology; 1993 Feb; 132(2):682-8. PubMed ID: 8093877
[TBL] [Abstract][Full Text] [Related]
6. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
Barton AC; Sibley DR
Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines.
Monsma FJ; Brassard DL; Sibley DR
Brain Res; 1989 Jul; 492(1-2):314-24. PubMed ID: 2665904
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
Hensler JG; Cotterell DJ; Dubocovich ML
J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878
[TBL] [Abstract][Full Text] [Related]
9. Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking.
Amlaiky N; Berger JG; Chang W; McQuade RJ; Caron MG
Mol Pharmacol; 1987 Feb; 31(2):129-34. PubMed ID: 3807891
[TBL] [Abstract][Full Text] [Related]
10. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB
Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
[TBL] [Abstract][Full Text] [Related]
12. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
13. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
14. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
[TBL] [Abstract][Full Text] [Related]
15. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
16. Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography.
Altar CA; Marien MR
J Neurosci; 1987 Jan; 7(1):213-22. PubMed ID: 2949066
[TBL] [Abstract][Full Text] [Related]
17. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
Leff SE; Creese I
Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
[TBL] [Abstract][Full Text] [Related]
18. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
Neve KA; Henningsen RA; Kinzie JM; De Paulis T; Schmidt DE; Kessler RM; Janowsky A
J Pharmacol Exp Ther; 1990 Mar; 252(3):1108-16. PubMed ID: 2138666
[TBL] [Abstract][Full Text] [Related]
19. In vivo binding of SCH 39166: a D-1 selective antagonist.
McQuade RD; Duffy RA; Coffin VL; Chipkin RE; Barnett A
J Pharmacol Exp Ther; 1991 Apr; 257(1):42-9. PubMed ID: 1826927
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
Santanavanich C; Ebadi M; Govitrapong P
J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
